Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug DevelopmentCarlos E. Sanz-Rodríguez, Kojo Mensa‐Wilmot|Molecular Pharmacology|2022Cited by 5